About the Authors

Jaime Moreno

Roles Data curation, Formal analysis, Investigation, Methodology, Software, Visualization, Writing – original draft

Affiliation Digital Science and Innovation, Computational Biology – AI & Digital Research, Novo Nordisk A/S, Maløv, Denmark

Lise Lotte Gluud

Roles Validation, Writing – review & editing

Affiliations Gastro Unit, Copenhagen University Hospital Hvidovre, Hvidovre, Denmark, Dept of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark

Elisabeth D. Galsgaard

Roles Validation, Writing – review & editing

Affiliation Global Translation, Novo Nordisk A/S, Maløv, Denmark

Henning Hvid

Roles Resources, Validation, Writing – review & editing

Affiliation Global Drug Discovery, Novo Nordisk A/S, Maløv, Denmark

Gianluca Mazzoni

Roles Conceptualization, Funding acquisition, Investigation, Project administration, Supervision, Validation, Visualization, Writing – original draft, Writing – review & editing

gcma@novonordisk.com (GM); vvda@novonordisk.com (VD)

Affiliation Digital Science and Innovation, Computational Biology – AI & Digital Research, Novo Nordisk A/S, Maløv, Denmark

Vivek Das

Roles Conceptualization, Funding acquisition, Investigation, Project administration, Resources, Supervision, Validation, Writing – review & editing

gcma@novonordisk.com (GM); vvda@novonordisk.com (VD)

Affiliation Digital Science and Innovation, Computational Biology – AI & Digital Research, Novo Nordisk A/S, Maløv, Denmark

Competing Interests

I have read the journal’s policy and the authors of this manuscript have the following competing interests: VD, JM, GM, EDG and HH are employed by Novo Nordisk A/S. VD, JM, GM, HH and EDG hold minor stock portions as part of an employee-offering program. The authors have also indicated that no competing interests exist. Author Lise Lotte Gluud has received speaker honorarium from Norgine, Astra Zeneca, Sobi, Alexion and Novo Nordisk, consultant honorarium from Pfizer, Becton, Dickinson and Novo Nordisk and research funding from Alexion, Gilead Sciences and Novo Nordisk.